Advanced search
Publication Cover
Journal of Medical Economics Volume 17, 2014 - Issue 10
Submit an article Journal homepage
3,542
Views
38
CrossRef citations to date
0
Altmetric
Cardiovascular: Original articles

Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program

Brahim K. BookhartJanssen Scientific Affairs, LLC Raritan, NJUSACorrespondence[email protected]
,
Lloyd HaskellJanssen Scientific Affairs, LLC Raritan, NJUSA
,
Luke BamberBayer Pharma AG WuppertalGermany
,
Maria WangBayer HealthCare Whippany, NJUSA
,
Jeff ScheinJanssen Scientific Affairs, LLC Raritan, NJUSA
&
Samir H. ModyJanssen Scientific Affairs, LLC Raritan, NJUSA
Pages 691-695 | Accepted 17 Jul 2014, Published online: 04 Aug 2014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.